![Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd3876/asset/eabd3554-f8de-405a-b624-ff84ce2a2fbf/assets/graphic/abd3876-f1.jpeg)
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine
![JCM | Free Full-Text | Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review JCM | Free Full-Text | Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review](https://pub.mdpi-res.com/jcm/jcm-11-00675/article_deploy/html/images/jcm-11-00675-g001.png?1643533470)
JCM | Free Full-Text | Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
![The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e0654799-d970-48d0-8ad1-4c0d0fd6bd05/joim13022-toc-0001-m.jpg)
The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library
![Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation](https://www.frontiersin.org/files/Articles/462543/fimmu-10-01609-HTML/image_m/fimmu-10-01609-g001.jpg)
Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
![Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-2131-4/MediaObjects/13075_2020_2131_Fig1_HTML.png)
Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort | Arthritis Research & Therapy | Full Text
Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management | Haematologica
![Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/11/1597/F1.large.jpg)
Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of “Non-criteria” Antiphospholipid Antibodies | The Journal of Rheumatology
![COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura](https://journals.sagepub.com/cms/10.1177/09612033211062523/asset/images/large/10.1177_09612033211062523-fig1.jpeg)
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) - Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, Laura
![Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019 Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019](https://journals.sagepub.com/cms/10.1177/0961203319864163/asset/images/large/10.1177_0961203319864163-fig1.jpeg)
Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019
![Laurent ARNAUD on Twitter: "❤️ EULAR recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://t.co/AxsCpTXgcn https://t.co/tnsarpvrXu" / Twitter Laurent ARNAUD on Twitter: "❤️ EULAR recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://t.co/AxsCpTXgcn https://t.co/tnsarpvrXu" / Twitter](https://pbs.twimg.com/media/FLPivXgVIAABZuS.jpg:large)
Laurent ARNAUD on Twitter: "❤️ EULAR recommendations for the management of #cardiovascular risk in patients with #lupus or aPL/APS 🎯 Link: https://t.co/AxsCpTXgcn https://t.co/tnsarpvrXu" / Twitter
![Introductory Chapter: Antiphospholipid Antibodies - A Laboratory Criterion for the Antiphospholipid Syndrome, but Also Bystanders in Infections, Cancer, and Other Conditions | IntechOpen Introductory Chapter: Antiphospholipid Antibodies - A Laboratory Criterion for the Antiphospholipid Syndrome, but Also Bystanders in Infections, Cancer, and Other Conditions | IntechOpen](https://www.intechopen.com/media/chapter/80872/media/F1.png)